Vir Biotechnology
VIR
VIR
196 hedge funds and large institutions have $656M invested in Vir Biotechnology in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 77 increasing their positions, 68 reducing their positions, and 39 closing their positions.
Holders
196
Holders Change
-19
Holders Change %
-8.84%
% of All Funds
2.84%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
21
Increased
77
Reduced
68
Closed
39
Calls
$1.28M
Puts
$8.95M
Net Calls
-$7.67M
Net Calls Change
-$8.4M
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$26.8M |
| 2 |
JFG
2
Jefferies Financial Group
New York
|
$8.13M |
| 3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$9.08M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$42.1M |
| 5 |
5
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$2.68M |
